Denosumab

Details

Files

Generic Name:

Denosumab

Project Status:

Complete

Therapeutic Area:

Osteoporosis, postmenopausal women

Manufacturer:

Amgen Canada Inc.

Call for patient/clinician input open:

August 13, 2010

Brand Name:

Prolia

Project Line:

Reimbursement Review

Project Number:

SR0208-000

Call for patient/clinician input closed:

September 17, 2010

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Osteoporosis, postmenopausal women

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

March 30, 2011

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Plain Language Recommendation View PDF

Last Updated : August 26, 2010